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Abstract
This article proposes an age-structured compartment model for ir-
reversible diseases with a pre-clinical state of undiagnosed cases that
precedes the diagnosis. The model is able to cope with mortality
rates differing between the pre-clinical and the clinical state (differen-
tial mortality). Applicability is tested in a hypothetical disease with
realistic incidence and mortality rates.
1 Introduction
Many non-communicable diseases (NCDs) progress unobserved before clini-
cal symptoms occur. Examples are certain types of cancer [Lao13], diabetes
[Bea14] and dementia [Hod11]. Mostly, reasons for the undetected progres-
sion may be the lack of early symptoms. Other reasons are missing awareness
of patients and physicians, lack of practical diagnostic tests or incoherent defi-
nitions for a diagnosis of the disease. In some cases, the progressing condition
may be completely unknown.
The next section introduces a compartment model with a pre-clinical stage
preceding the clinical stage. As in the field of infectious disease epidemiology
we describe the disease dynamics of a population by differential equations
involving the transition rates between the compartments [Vyn10]. The model
described here is able to cope with secular trends, i.e. involves calendar time
t, and the different ages a of the subjects in the population. Sometimes these
models are called age-structured.
Although considering a pre-clinical state preceding a diagnosis is at least go-
ing back to 1969 [Zel69] and a considerable amount of work has been devoted
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to compartment models since then, to our knowledge a description using dif-
ferential equations in calendar time t and age a is new. Furthermore, other
models distinguish between disease-specific mortalities and other causes of
death (e.g. [Tol78]). However, we consider this approach critical, because
there might be cases where the cause of death is not clearly attributable. Is
a death by an infection (say pneumonia) due to the disease (e.g. the im-
munosuppressive treatment in cancer) or is it independent from the disease?
In practical cases this is difficult to judge.
In the third section the compartment model is used in an example of an partly
unobserved disease. We mimic the situation that a hypothetical population
suffers from a fictional NCD that is detected at a certain point in time. From
that time on, the medical community is aware, starts to diagnose and treat
the newly discovered condition.
2 Diagnosis Model
In modelling chronic (irreversible) diseases, often the three-state model (com-
partment model) in Figure 1 is used. The numbers of persons in the states
Normal, Undiagnosed and Diagnosed are denoted by S, U, and C. The tran-
sition intensities (synonym: rates) between the states are: the incidence rates
λ0, λ1 and the mortality rates µ0, µ1 and µ2. These rates generally depend on
the calendar time t and the age a.
Although the inclusion of the disease duration d is also possible [Bri13], here-
inafter it is assumed that m1 does not depend on d. Analogously to [Bri12b],
we look for the numbers S(t, a), U(t, a) and C(t, a) of healthy, undiagnosed
and diagnosed persons in terms of differential equations, which can be de-
rived from the disease model in Figure 1. For the healthy persons we get the
following initial value problem of Cauchy type:
(∂t + ∂a)S(t, a) = −
(
µ0(t, a) + λ0(t, a)
)
S(t, a)(1)
S(t, 0) = S0(t).
Here S0(t) is the number of (healthy) newborns
1 at calendar time t. The
notation ∂x denotes the partial derivative with respect to x, x ∈ {t, a}.
The numbers U and C of diseased persons without and with diagnosis are
1Here we just consider diseases contracted after birth.
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Figure 1: Chronic disease model with four states and the corresponding
transition rates. People in the state Normal are healthy with respect to
the disease under consideration. After onset of the disease, they change to
state Undiagnosed and later to the state D. The absorbing state Dead can
be reached from all other states. The numbers of persons in the states and
the transition rates depend on calendar time t and age a.
described similarly:
(∂t + ∂a)U(t, a) = −
(
µ1(t, a) + λ1(t, a)
)
U(t, a) + λ0(t, a)S(t, a)(2)
U(t, 0) = 0.
(∂t + ∂a)C(t, a) = −µ2(t, a)C(t, a) + λ1(t, a)U(t, a)(3)
C(t, 0) = 0.
After defining N(t, a) = S(t, a) + U(t, a) + C(t, a) and
p0(t, a) = S(t,a)/N(t,a)
p1(t, a) = U(t,a)/N(t,a)
p2(t, a) = C(t,a)/N(t,a),
the overall mortality (general mortality) µ in the population may be written
as
µ = p0 µ0 + p1 µ1 + p2 µ2.
By using p0 + p1 + p2 = 1, the partial differential equations (2) and (3) read
as
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(∂t + ∂a)p1 = −
(
λ0 + λ1 + µ1 − µ
)
p1 − λ0 p2 + λ0(4)
(∂t + ∂a)p2 = λ1 p1 −
(
µ2 − µ
)
p2.(5)
Together with the initial conditions p1(t, 0) = p2(t, 0) = 0 for all t, the system
(4) - (5) completely describes the dynamics of the disease in the considered
population. The values of p0 are obtained by using p0 = 1−p1−p2. Note that
the system (4) - (5) does not explicitly depend on the mortality of the healthy
subjects µ0, which is typically unknown. The remaining rates (λ0, λ1, µ1, µ2)
are either accessible by (specially designed) epidemiological studies or by
official vital statistics (µ).
3 Simulation
We use system (4) - (5) to describe a hypothetical irreversible disease, which
is undiagnosed until a specific point in time t⋆. At t⋆ the disease is detected
and diagnosed henceforth. As a consequence, after t⋆ the prevalence p1 of un-
detected cases decreases whereas the prevalence p2 of detected cases increases.
The general mortality µ is chosen as the (approximated) general mortality
of the German male population in from 1900 (t = 0) to 2010 (t = 110 :)
µ(t, a) = exp
(
β0(t) + β1(t) a
)
,
with β0(t) = −7.078 − 0.02592 t and β1(t) = 0.06401 + 2.455 10
−4 t. For
simplicity, the mortality rates µℓ, ℓ = 1, 2, are assumed to be proportional
to µ : µ1 = 3.5µ and µ2 = 2.5µ. The factor for µ1 is chosen to be larger than
the one for µ2, because in contrast to the the persons in the detected state
the persons in the undetected state cannot be treated for the disease.
The rates λℓ, ℓ = 0, 1, are modified incidence rates of dementia in German
males [Zie09]. The rate λ0 is the 1.5-fold rate of the values in [Zie09], which
mimics one undetected case per two detected cases for t ≥ 75, see Table 1.
For year t = 75 the rates λ1 are also shown in Table 1. There is a secular trend
in λ1 mimicking the increasing awareness for the disease. In the simulation,
λ1 increases by 1 % per year for all ages a.
If we solve the system (4) - (5) by the methods of characteristics, we obtain
the prevalences of the undiagnosed and diagnosed disease as shown in Figures
2 and 3, respectively. The qualitative change after 1975 (t = 75) in both
prevalences p1 and p2 is clearly visible in the upper right corner of the figures.
For better comparison, the age-specific prevalences in 1970 (t = 70) and 1980
(t = 80) are additionally shown in Figure 4. In 1970, there are no diagnosed
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Age Incidence λ0 Incidence λ1 in the year 75
(years) (per 100 person-years) (per 100 person-years)
≤ 62.5 0 0
67.5 0.3 3.3
72.5 0.7 7.8
77.5 1.7 20
82.5 3.0 33
87.5 5.2 58
92.5 7.6 510
97.5 9.9 1340
≥ 100 11.2 4110
Table 1: Age-specific incidence rates λ0 and λ1. For the t > 75 the rate λ1
increases by 1% annually for all ages.
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Figure 2: Prevalence of the undiagnosed disease (p1) over year and age (left).
The colour corresponds to value of the prevalence (coding scheme on the
right hand side).
cases (the hypothetical disease is not detected yet). The prevalence of the
undiagnosed cases (p1) is peaking at about 16% at the age of 91 years. Ten
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Figure 3: Prevalence of the diagnosed disease (p2) over year and age (left).
The colour corresponds to the value of prevalence (coding scheme on the
right hand side).
years later, the disease has been detected and the medical community is
making diagnoses. Hence, the prevalence of the undiagnosed disease has
tremendously decreased – to less than 8%. Especially in the higher age
groups (≥ 95) the physicians are aware and detect a high proportion of
cases. Thus, the prevalence of diagnosed cases (p2) has increased a lot.
It is amazing, how much the overall prevalence (p1 + p2) in 1970 differs from
the one in 1980 (cf. Figure 5). This is an effect of the lowered mortality for
those diseased persons who have been detected (and are treated since then).
Since the mortality µ2 is much lower than µ1, the overall survival of the
diseased persons is improved after 1975 and the overall prevalence increases.
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Figure 4: Age-specific prevalence of the undiagnosed (red, dashed lines) and
the diagnosed disease (orange, solid lines) in 1970 (t = 70, left) and in 1980
(t = 80, right).
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Figure 5: Overall age-specific prevalence (p1+p2) in 1970 (black dashed line)
and in 1980 (blue solid line).
8
4 Discussion
In this work, a novel approach for analysing epidemiological measures of a
chronic disease is proposed. With a view to the chronic (incurable) disease, a
pre-clinical state is considered in which the disease is at least partly undiag-
nosed. The situation is described in an age-structured compartment model
unsing a set of partial differential equations.
There are various chronic diseases that have an pre-clinical state preceding
a diagnosis. Examples were given in the introductory section of this article.
Other diseases with an asymptomatic pre-clinical state are chronic kidney
disease (CKD), hypertension and arteriosclerosis.
So far, we just considered non-communicable diseases. However some incur-
able infectious diseases, such as HIV or hepatitis C, also have an asymp-
tomatic pre-clinical phase. Thus, the compartment model of Figure 1 as well
may be useful in these cases.
In an example we have demonstrated the applicability of the modelling frame-
work for a hypothetical chronic disease that has been detected at a specific
point in time and has been diagnosed and treated since then. Examples ana-
logue to the one shown may give insight about the ratio between undiagnosed
and diagnosed cases in a chronic disease.
A final remark about the system (4) - (5) and the example: Since the tran-
sition rates for the compartment model are assumed to be known, we speak
of a forward problem [Bri12a]. There is an associated inverse problem, which
might be interesting.
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